Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) CFO Cheng Yanling resigned due to personal reasons, according to a Saturday filing on the Shanghai Stock Exchange.
Cao Xu was named CFO of the company, succeeding Cheng. Both changes were effective July 19.
The company's shares were up by around 1% in Hong Kong and Shenzhen recently.
Price (HKD): $5.23, Change: $+0.03, Percent Change: +0.58%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments